On 2024-11-14, Omega Therapeutics, Inc. (OMGAQ) announced earnings per share of $-0.30 for the fiscal quarter ending 2024-09-30, missing the average analyst estimate of $-0.29.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2024-11-14 | 2024-09-30 | $-0.29 | $-0.30 |
2024-08-06 | 2024-06-30 | $-0.36 | $-0.30 |
2024-05-06 | 2024-03-31 | $-0.38 | $-0.36 |
2024-03-28 | 2023-12-31 | $-0.46 | $-0.37 |
2023-11-09 | 2023-09-30 | $-0.56 | $-0.40 |
2023-08-03 | 2023-06-30 | $-0.51 | $-0.54 |
2023-05-04 | 2023-03-31 | $-0.64 | $-0.50 |
2023-03-01 | 2022-12-31 | $-0.62 | $-0.64 |
2022-11-08 | 2022-09-30 | $-0.63 | $-0.54 |
2022-08-04 | 2022-06-30 | $-0.54 | $-0.54 |
2022-05-04 | 2022-03-31 | $-0.57 | $-0.42 |
2022-03-10 | 2021-12-31 | $-0.57 | $-0.44 |
2021-11-10 | 2021-09-30 | $-0.49 | $-0.57 |
2021-09-10 | 2021-06-30 | $-1.46 | $-3.36 |